Collplant Biotechnologies Stock Options

CLGN Stock  USD 3.40  0.10  2.86%   
Collplant Biotechnologies' latest option contracts expiring on April 17th 2025 are carrying combined implied volatility of 3.29. The Collplant Biotechnologies option chain provides detailed quote and price information for the current Collplant Biotechnologies option contracts. It shows all of Collplant Biotechnologies' listed puts, calls, expiration dates, strike prices, and other pricing information.

In The Money vs. Out of Money Option Contracts on Collplant Biotechnologies

Analyzing Collplant Biotechnologies' in-the-money options over time can help investors to take a profitable long position in Collplant Biotechnologies regardless of its overall volatility. This is especially true when Collplant Biotechnologies' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Collplant Biotechnologies' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Collplant Biotechnologies' stock while costing only a fraction of its price.
In The Money Calls:Out Of Money Calls:In The Money Puts:Out Of Money Puts:100%
Please note that buying 'in-the-money' options on Collplant Biotechnologies lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Collplant Biotechnologies' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Collplant Biotechnologies contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Collplant Stock moves the wrong way.

Collplant Biotechnologies In The Money Call Balance

When Collplant Biotechnologies' strike price is surpassing the current stock price, the option contract against Collplant Biotechnologies stock is said to be in the money. When it comes to buying Collplant Biotechnologies' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Out Of The Money66.67%In The Money33.33%100%
While 'out-of-the-money' option contracts written on Collplant Biotechnologies are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Collplant Current Options Market Mood

Collplant Biotechnologies' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Collplant Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
100.0%

Put-to-Call Volume

Unfortunately, most Collplant Biotechnologies' options investors are not very successful. Collplant Biotechnologies' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Collplant contract

Base on the Rule 16, the options market is currently suggesting that Collplant Biotechnologies will have an average daily up or down price movement of about 0.21% per day over the life of the 2025-04-17 option contract. With Collplant Biotechnologies trading at USD 3.4, that is roughly USD 0.006991. If you think that the market is fully incorporating Collplant Biotechnologies' daily price movement you should consider buying Collplant Biotechnologies options at the current volatility level of 3.29%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Collplant Biotechnologies options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Collplant calls. Remember, the seller must deliver Collplant Biotechnologies stock to the call owner when a call is exercised.

Collplant Biotechnologies Option Chain

When Collplant Biotechnologies' strike price is surpassing the current stock price, the option contract against Collplant Biotechnologies stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Collplant Biotechnologies' option chain is a display of a range of information that helps investors for ways to trade options on Collplant. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Collplant. It also shows strike prices and maturity days for a Collplant Biotechnologies against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
CLGN250417C00002500122.50.05 - 1.31.0In
Call
CLGN250417C0000500065.00.0 - 4.30.25Out
Call
CLGN250417C0000750007.50.0 - 4.34.3Out
 Put
CLGN250417P0000250002.50.0 - 0.450.45Out
 Put
CLGN250417P0000500005.00.0 - 2.252.25In
 Put
CLGN250417P0000750007.53.8 - 6.23.8In

Collplant Biotechnologies Market Cap Over Time

   Market Cap   
       Timeline  

Collplant Total Stockholder Equity

Total Stockholder Equity

34.22 Million

32.6M34.2M
At this time, Collplant Biotechnologies' Total Stockholder Equity is very stable compared to the past year.

Collplant Biotechnologies Corporate Management

Oren FahimipoorVice OperationsProfile
Michal RoytmanVP MarketingProfile
Pr ShoseyovFounder ScientistProfile
Eran CPADeputy CFOProfile
Elana GazalVice DevelopmentProfile
When determining whether Collplant Biotechnologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Collplant Biotechnologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Collplant Biotechnologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Collplant Biotechnologies Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collplant Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collplant Biotechnologies. If investors know Collplant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collplant Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.53)
Revenue Per Share
0.057
Quarterly Revenue Growth
(0.91)
Return On Assets
(0.38)
Return On Equity
(0.71)
The market value of Collplant Biotechnologies is measured differently than its book value, which is the value of Collplant that is recorded on the company's balance sheet. Investors also form their own opinion of Collplant Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Collplant Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collplant Biotechnologies' market value can be influenced by many factors that don't directly affect Collplant Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collplant Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Collplant Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collplant Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
News Freq…Investor S…